The company said revenues in its diagnostics business unit rose 62 percent during the quarter.

The company is eyeing a launch for its IVD kits at the beginning of next year, as evidence grows for the integration of TMB analysis into the clinical care of cancer patients.

The Tsimshian people of coastal British Columbia and southern Alaska experienced changes in genetic diversity following contact with Europeans.

The institute will use the funds to continue combining genomic and digital technologies with bioinformatics to advance medical research and clinical care.

An exome- and expression-based analysis of 304 DLBCL cases led to five molecular subtypes, offering insights into disease pathogenesis and treatment outcomes.

A Phase III randomized trial uncovered enhanced carboplatin response in advanced triple-negative breast cancer patients with germline mutations affecting BRCA1/2.

The New York Times reports that new director of the US Centers for Disease Control and Prevention makes more than other agency heads.

Science speaks with Columbia University's Yaniv Erlich about using genetic genealogical data to identify people.

In PLOS this week: cancer predisposition among Cowden/Cowden-like and Bannayan-Riley-Ruvalcaba syndrome patients, and more.

CBS News' 60 Minutes dives into CRISPR gene editing and how it could be used to treat disease.

Revenues fell as an increase in sales of test cartridges for its Unyvero molecular diagnostic instrument was offset by a decline in system and service sales.

The five CROs will be able to offer DSP analyses to their customers through a technology access program ahead of NanoString's planned platform launch in 2019.

The firm said it will use the funds to continue developing and then commercialize its next-generation sequencing technology.

Last week, GenomeWeb's readers were most interested in a new CRISPR company cofounded by Jennifer Doudna.

Tumor sequencing tests may pick up age-associated mutations called clonal hematopoiesis, a noncancerous phenomenon that can have clinical implications.

The panel is designed to measure genetic markers in whole-blood samples in order to predict which patients are likely to experience a severe, relapsing form of the disease.

Exact Sciences Chief Operating Officer Maneesh Arora will be leaving the company at the end of the year. During a conference call with analysts following the release of the company's first quarter earnings, Exact CEO Kevin Conroy announced that Arora "will transition to a life outside of Exact Sciences," adding that he will spend the rest of 2018 "focusing his operational and strategic rigor on the priority of advancing our pipeline plans to fuel our future success." The company does not anticipate finding a replacement COO at this time, Conroy noted.

Holger Reithinger has resigned from Curetis' supervisory board effective April 30. He had been on the board since the company went public in 2015. Reithinger is a general partner at venture capital firm Forbion. Curetis' board now has six members. His replacement has not been named, and the company is "exploring options ... to further evolve" its board composition, Curetis said. 

The University of Nebraska Medical Center has created a SNOMED-CT and LOINC extension to make a cancer pathology report as "readily presentable as a CBC."

Using genetic probes and fluorescent scanning, the firm plans to market the $20 test for pathogens that cause urinary tract infections and biological warfare.

A brief recap of Genetics/Genomics news the week of Apr 27, 2018: PerkinElmer, Beckton Dickinson, MDxHealth, Wistar Inst, Novacyt, Genomenon, Thermo Fisher Scientific, Enzo Biochem, Meridian Bioscience, Wefen, Personalis, IntegrGen

An international team of researchers combined data from seven cohorts to uncover 30 novel depression-linked loci, including ones that overlap with schizophrenia.

The company said it will use the proceeds for the US commercial launch of its Unyvero molecular diagnostic platform, among other things.

A familial match at a genetic genealogy site has led police to make an arrest in the decades-old Golden State Killer case, the Sacramento Bee reports.